Cybin Inc. (OTCMKTS:CLXPF – Get Free Report) reached a new 52-week high on Tuesday . The stock traded as high as $10.90 and last traded at $10.71, with a volume of 278832 shares traded. The stock had previously closed at $10.64.
Cybin Price Performance
The stock has a market capitalization of $1.52 billion and a PE ratio of -42.71. The company has a 50 day moving average price of $9.97 and a 200-day moving average price of $3.67.
Cybin Company Profile
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
Featured Articles
- Five stocks we like better than Cybin
- Compound Interest and Why It Matters When Investing
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- How to Use Stock Screeners to Find Stocks
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Industrial Products Stocks Investing
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.
